A Comprehensive Investigation of the Causes and Mitigation of Dog Parvovirus Illness
Abstract
Vaccination and rapid veterinarian treatment are crucial for the prevention and treatment of this highly infectious and sometimes fatal disease in dogs. Research focusing on particular regions is necessary to have a better understanding of the prevalence and related determinants of canine parvovirus (CPV), which continues to be a major global health problem for dogs. The dataset used in this study comes from Western India and includes 150 dog examinations. The variables that were examined include breed, age, sex, vaccination status and clinical symptoms. It is important to note that the frequency of CPV varied by breed, with Indigenous breeds showing the greatest prevalence at 43.33%. This highlights the need for breed-specific preventative interventions. One important consideration is the age of the dog. Puppies are especially at risk since there is a statistically significant correlation between CPV infection and dogs that are three months old or less (42.37%). The lack of statistical significance in the sex-based changes suggests that the risk of infection is similar in male and female dogs. The efficiency of vaccination in reducing CPV infection was highlighted by the much lower incidence of unvaccinated dogs at 18.46%, highlighting the crucial impact of vaccination status. An association between the severity of CPV and certain symptoms, such as vomiting and watery diarrhea with a bad smell, was found in an examination of clinical variables. To reduce the effect of CPV on dog populations, this research adds important new information to our understanding of the virus's epidemiology in Western India and highlights the significance of vaccination regimens and breed-specific factors.
References
Sayed-Ahmed, M. Z., Elbaz, E., Younis, E., & Khodier, M. (2020). Canine parvovirus infection in dogs: Prevalence and associated risk factors in Egypt. World's Veterinary Journal, 10(4), 571-577. DOI: https://doi.org/10.54203/scil.2020.wvj68
Pereira, K. H. N. P., da Mata Fuchs, K., Hibaru, V. Y., dos Santos Correia, L. E. C., Ferreira, J. C. P., de Souza, F. F., ... & Lourenço, M. L. G. (2022). Neonatal sepsis in dogs: Incidence, clinical aspects and mortality. Theriogenology, 177, 103-115. DOI: https://doi.org/10.1016/j.theriogenology.2021.10.015
Mia, M. M., & Hasan, M. (2021). Update on canine parvovirus infection: a review from the literature. Veterinary Sciences: Research and Reviews, 7(2), 92-100. DOI: https://dx.doi.org/10.17582/journal.vsrr/2021.7.2.92.100
Behdenna, A., Lembo, T., Calatayud, O., Cleaveland, S., Halliday, J. E., Packer, C., ... & Viana, M. (2019). Transmission ecology of canine parvovirus in a multi-host, multi-pathogen system. Proceedings of the Royal Society B, 286(1899), 20182772. DOI: https://doi.org/10.1098/rspb.2018.2772
dos Santos Alves, F., Barbosa, B. C., das Graças Coelho, N. D., de Oliveira Pinto, P. C., Campos, M. T. G., Horta, R. S., ... & de Oliveira Paes, P. R. (2019). Clinical and hematological prognostic factors in dogs with parvoviral enteritis and sepsis. Semina: Ciências Agrárias, 40(4), 1477-1488. DOI: https://doi.org/10.5433/1679-0359.2019v40n4p1477
Nurden, A. T., & Nurden, P. (2020). Inherited thrombocytopenias: history, advances and perspectives. Haematologica, 105(8), 2004. DOI: https://doi.org/10.3324%2Fhaematol.2019.233197
Song, Y., Zhang, M., Yin, L., Wang, K., Zhou, Y., Zhou, M., & Lu, Y. (2020). COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2). International journal of antimicrobial agents, 56(2), 106080. DOI: https://doi.org/10.1016/j.ijantimicag.2020.106080
Morgan, L., Protopopova, A., Birkler, R. I. D., Itin-Shwartz, B., Sutton, G. A., Gamliel, A., ... & Raz, T. (2020). Human–dog relationships during the COVID-19 pandemic: Booming dog adoption during social isolation. Humanities and Social Sciences Communications, 7(1). DOI: https://doi.org/10.1057/s41599-020-00649-x
Eregowda, C. G., De, U. K., Singh, M., Prasad, H., Sarma, K., Roychoudhury, P., ... & Behera, S. K. (2020). Assessment of certain biomarkers for predicting survival in response to treatment in dogs naturally infected with canine parvovirus. Microbial pathogenesis, 149, 104485. DOI: https://doi.org/10.1016/j.micpath.2020.104485
Kelman, M., Barrs, V. R., Norris, J. M., & Ward, M. P. (2020). Canine parvovirus prevention and prevalence: Veterinarian perceptions and behaviors. Preventive veterinary medicine, 174, 104817. DOI: https://doi.org/10.1016/j.prevetmed.2019.104817
Poudel, U., Dahal, U., & Aryal, A. (2020). Canine parvovirus infection in young German Shepherd dog: A Case Report. Hemoglobin, 8, 11-19. DOI: http://dx.doi.org/10.29322/IJSRP.10.03.2020.p9980
Mazzaferro, E. M. (2020). Update on canine parvoviral enteritis. Veterinary Clinics: Small Animal Practice, 50(6), 1307-1325. DOI: https://doi.org/10.1016/j.cvsm.2020.07.008
Le, T. H., Nguyen, H. D. M., Doan, H. P., Truong, P. L., Tu, T. K. L., Nguyen, H. Q., ... & Pornchai, P. (2020). Risk factors associated with canine parvovirus disease in dogs: A case-control study. The Journal of Agriculture and Development, 19(6), 32-38. DOI: https://doi.org/10.52997/jad.4.06.2020
Chalifoux, N. V., Parker, S. E., & Cosford, K. L. (2021). Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001‐2018). Journal of Veterinary Emergency and Critical Care, 31(3), 402-413. DOI: https://doi.org/10.1111/vec.13052
Zobba, R., Visco, S., Sotgiu, F., Pinna Parpaglia, M. L., Pittau, M., & Alberti, A. (2021). Molecular survey of parvovirus, astrovirus, coronavirus, and calicivirus in symptomatic dogs. Veterinary Research Communications, 45, 31-40. DOI: https://doi.org/10.1007/s11259-020-09785-w
Doyle, E. (2021). Canine Parvovirus and Other Canine Enteropathogens. Infectious Disease Management in Animal Shelters, 321-336. DOI: https://doi.org/10.1002/9781119294382.ch14
Qi, S., Zhao, J., Guo, D., & Sun, D. (2020). A mini-review on the epidemiology of canine parvovirus in China. Frontiers in veterinary science, 7, 5. DOI: https://doi.org/10.3389/fvets.2020.00005
Kelman, M., Ward, M. P., Barrs, V. R., & Norris, J. M. (2019). The geographic distribution and financial impact of canine parvovirus in Australia. Transboundary and emerging diseases, 66(1), 299-311. DOI: https://doi.org/10.1111/tbed.13022
Singh, M., Manikandan, R., De, U. K., Chander, V., Paul, B. R., Ramakrishnan, S., & Maramreddy, D. (2022). Canine Parvovirus-2: An emerging threat to young pets. In Recent Advances in Canine Medicine. IntechOpen. DOI: 10.5772/intechopen.104846
Kulkarni, M. B., Deshpande, A. R., Gaikwad, S. S., Majee, S. B., Suryawanshi, P. R., & Awandkar, S. P. (2019). Molecular epidemiology of Canine parvovirus shows CPV-2a genotype circulating in dogs from western India. Infection, Genetics, and Evolution, 75, 103987. DOI: https://doi.org/10.1016/j.meegid.2019.103987
